Announcements Trials
Browse Landscape

Phase

Phase 2 16Phase 3 6Phase 1/2 4Phase 1 3Phase NA 2Phase 4 2Phase 2/3 1

Status

Completed 23Unknown 17Terminated 6Active not recruiting 4Withdrawn 2

Sponsor Class

NETWORK 2INDUSTRY 2OTHER 1NIH 1

Study Type

Interventional 6

Sponsor

Cancer Type

Thoracic 4Head & Neck 1Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Urinary Bladder Neoplasms 1Stage IV EGFR Mutated Non-Small Cell Lung Cancer 1Lung Neoplasms 1Head and Neck Neoplasms 1

Interventions

Cisplatin 62Carboplatin 52Paclitaxel 49Radiotherapy 47Docetaxel 42Gemcitabine 38Cyclophosphamide 36Rituximab 33Capecitabine 28Fluorouracil 27Dexamethasone 27Doxorubicin 26Prednisone 21Bevacizumab 20Pemetrexed 19Oxaliplatin 18Leucovorin 18pembrolizumab 17Vincristine 17Etoposide 17Cytarabine 15Imatinib Mesylate 14Drug Therapy 14Irinotecan 13Filgrastim 13Zoledronic Acid 12Trastuzumab 12Radiosurgery 12Erlotinib Hydrochloride 12Goserelin 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 3 × Terminated × Gefitinib × Clear all
NCT02588261 2024-12-10

SOLAR

Astellas Pharma Inc

Phase 3 Terminated
530 enrolled 25 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00352079 2023-08-04

BCG With or Without Gefitinib in Treating Patients With High-Risk Bladder Cancer

Canadian Cancer Trials Group

Phase 3 Terminated
41 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT02893332 2021-02-03

Sindas

Sichuan Provincial People's Hospital

Phase 3 Terminated
200 enrolled
Thoracic

Stage IV EGFR Mutated Non-Small Cell Lung Cancer

NCT00088907 2015-05-06

Phase III Trial Of Docetaxel Versus Docetaxel Plus ZD1839 In Head And Neck Cancer

National Cancer Institute (NCI)

Phase 3 Terminated
270 enrolled 8 charts
Head & Neck

Head and Neck Neoplasms

NCT00091156 2012-07-16

Gefitinib After Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Terminated
598 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00234468 2011-05-20

Iressa vs Placebo as Maintenance Therapy in Locally Advanced NSCLC

AstraZeneca

Phase 3 Terminated
490 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡